| Jeffrey Cobb, RN | |
|
190 Main St, Hampstead, NH 03841-2070 | |
| (603) 339-0972 | |
| Not Available |
| Full Name | Jeffrey Cobb |
|---|---|
| Gender | Male |
| Speciality | Registered Nurse |
| Location | 190 Main St, Hampstead, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386065035 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 202994 (Massachusetts) | Primary |
| 163W00000X | Registered Nurse | 03841-21 (New Hampshire) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Cobb, RN 190 Main St, Hampstead, NH 03841-2070 Ph: (603) 339-0972 | Jeffrey Cobb, RN 190 Main St, Hampstead, NH 03841-2070 Ph: (603) 339-0972 |
News Archive
The New York Times: "The Senate Finance Committee has opened an investigation into patient deaths and allegations of substandard treatment at long-term care hospitals, small specialty medical centers that treat chronically ill patients. The investigation focuses on the Select Medical Corporation, a for-profit corporation that runs 89 long-term care hospitals, more than any other company."
B55α is one of the regulatory subunits of the PP2A phosphatase. This phosphatases has been associated to the control of many biological functions but the multiplicity of complexes that can be formed by the combination of different subunits renders this protein hard in its understanding.
ViroPharma Incorporated, an international biopharmaceutical company committed to developing and commercializing innovative products that address unmet medical needs and rare diseases, today announced the results of a Phase 2 study of VP20621 (non-toxigenic Clostridium difficile; NTCD) a novel treatment approach for preventing recurrent C. difficile infections.
Cocrystal Discovery, Inc., a biopharmaceutical company focused on the discovery and development of novel antiviral therapeutics for the treatment of serious and chronic viral diseases, announced today that it has received $733,438 in grants from the Qualified Therapeutic Discovery Project (QTDP) administered under section 48D of the Internal Revenue Code.
For years, the common narrative in human developmental neuroimaging has been that gray matter in the brain - the tissue found in regions of the brain responsible for muscle control, sensory perception such as seeing and hearing, memory, emotions, speech, decision making, and self-control - declines in adolescence, a finding derived mainly from studies of gray matter volume and cortical thickness (the thickness of the outer layers of brain that contain gray matter).
› Verified 7 days ago
Mrs. Janis Helen Mosher, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 70 Bloody Brook Rd, Hampstead, NH 03841 Phone: 603-770-3282 | |
Kayla Digloria, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 50 Beverly Dr, Hampstead, NH 03841 Phone: 978-857-0458 | |
Tammy Marie Wilson, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 10 Jody Lane, Hampstead, NH 03841 Phone: 603-329-6144 | |
Mr. Christopher Morgan Mccarthy, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 57 Main St, Hampstead, NH 03841 Phone: 617-835-0632 | |
Reid Gourley, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 218 East Rd, Hampstead, NH 03841 Phone: 603-329-5311 |